Cargando…

Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia

OBJECTIVE: Retinopathy is an established microvascular complication of type 2 diabetes mellitus (T2DM), but its independent relationship with macrovascular and other microvascular complications is less well defined across the spectrum of kidney disease in T2DM. We examined the prognostic value of re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bello, Natalie A, Pfeffer, Marc A, Skali, Hicham, McGill, Janet B, Rossert, Jerome, Olson, Kurt A, Weinrauch, Larry, Cooper, Mark E, de Zeeuw, Dick, Rossing, Peter, McMurray, John J V, Solomon, Scott D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212578/ https://www.ncbi.nlm.nih.gov/pubmed/25452859 http://dx.doi.org/10.1136/bmjdrc-2013-000011

Ejemplares similares

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
por: Rossing, Peter, et al.
Publicado: (2022)

Comparative Effectiveness of the Sodium–Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney Events
por: Xie, Yan, et al.
Publicado: (2020)

Effect of High-Intensity Interval Training on Glycemic Control in Adults With Type 1 Diabetes and Overweight or Obesity: A Randomized Controlled Trial With Partial Crossover
por: Lee, Angela S., et al.
Publicado: (2020)

Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study
por: Simó, Rafael, et al.
Publicado: (2019)

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria
por: Rathcke, Camilla Noelle, et al.
Publicado: (2009)

Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial
por: Kraus, William E, et al.
Publicado: (2018)

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
por: Charytan, David M, et al.
Publicado: (2023)

Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
por: Sveen, Kari Anne, et al.
Publicado: (2021)

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
por: Zobel, Emilie H, et al.
Publicado: (2021)

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial
por: Persson, Frederik, et al.
Publicado: (2021)

Polygenic Prediction of Type 2 Diabetes in Africa
por: Chikowore, Tinashe, et al.
Publicado: (2022)

Noninvasive Evaluation of Neural Impairment in Subjects With Impaired Glucose Tolerance
por: Putz, Zsuzsanna, et al.
Publicado: (2009)

Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis
por: McMillan, Jacqueline M, et al.
Publicado: (2018)

Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome
por: Ooi, Esther M.M., et al.
Publicado: (2008)

Fitness, Fatness, and Survival in Adults With Prediabetes
por: McAuley, Paul A., et al.
Publicado: (2014)

Multiple sleep dimensions and type 2 diabetes risk among women in the Sister Study: differences by race/ethnicity
por: McWhorter, Ketrell L, et al.
Publicado: (2019)

Physical activity and cardiometabolic health in adolescents with type 2 diabetes: a cross-sectional study
por: Slaght, Jana L, et al.
Publicado: (2021)

Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2022)

Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study
por: Strongman, Helen, et al.
Publicado: (2018)

A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes
por: Berg, David D., et al.
Publicado: (2021)

Dysglycemia and a History of Reproductive Risk Factors
por: McDonald, Sarah D., et al.
Publicado: (2008)

Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial
por: Menon, Venu, et al.
Publicado: (2020)

A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment
por: Mariam, Arshiya, et al.
Publicado: (2021)

Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans
por: Xie, John, et al.
Publicado: (2021)

High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study
por: Whelton, Seamus P., et al.
Publicado: (2017)

Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2020)

Sex Differences in the Risk of Coronary Heart Disease Associated With Type 2 Diabetes: A Mendelian Randomization Analysis
por: Peters, Tricia M., et al.
Publicado: (2021)

Uptake and impact of the English National Health Service digital diabetes prevention programme: observational study
por: Ross, Jamie Anne Dolan, et al.
Publicado: (2022)

Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis
por: Klonoff, David C., et al.
Publicado: (2021)

Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening
por: Anderson, Jana J, et al.
Publicado: (2021)

Impact of weight loss on waist circumference and the components of the metabolic syndrome
por: Rothberg, Amy E, et al.
Publicado: (2017)

Nondiabetic Glucometabolic Status and Progression of Aortic Stiffness: The Whitehall II Study
por: McEniery, Carmel M., et al.
Publicado: (2017)

One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2008)

Physical Activity and the Metabolic Syndrome in Elderly German Men and Women: Results from the population-based KORA Survey
por: Hahn, Valerie, et al.
Publicado: (2009)

Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels
por: Utzschneider, Kristina M., et al.
Publicado: (2009)

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial
por: Dagogo-Jack, Samuel, et al.
Publicado: (2021)

Objectively assessed physical activity, adiposity, and inflammatory markers in people with type 2 diabetes
por: Hamer, Mark, et al.
Publicado: (2014)

High prevalence of cardiovascular risk factors and insulin resistance 6 years after hyperglycemia first detected in pregnancy in Cape Town, South Africa
por: Chivese, Tawanda, et al.
Publicado: (2019)

Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.
por: Basu, Sanjay, et al.
Publicado: (2018)

Hyperinsulinemia in African-American Adolescents Compared With Their American White Peers Despite Similar Insulin Sensitivity: A reflection of upregulated β-cell function?
por: Hannon, Tamara S., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_phu9c01daunv0mnq1k4ntslpdb